GERRI NORMAN: Open Payments
NPI 1942478292 · KERRVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$235 in 11 payments from 5 companies in 2025. Trend: 2023 $421 · 2024 $207 · 2025 $235
Food & beverage: $235
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $71 |
| Teva Pharmaceuticals USA, Inc. | 3 | $70 |
| E.R. Squibb & Sons, L.L.C. | 3 | $61 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Neurocrine BioSciences, Inc. | 1 | $15 |
Products named: UZEDY, COBENFY, ABILIFY ASIMTUFII, REXULTI, Auvelity, INGREZZA.
Industry payments across TX — which companies pay providers there.
